-- BV Affects 21 Million U.S. Women; As many as 50% Experience Recurrent BV Within Six Months of Treatment -- In a focused clinical study of 24 women with recurrent BV, once-weekly dosing with ...
Roche’s cobas® BV/CV PCR assay aims to address frequent misdiagnosis of bacterial vaginosis and Candida vaginitis. The duplex test detects both conditions from one swab with high specificity, enabling ...